Hereditary angioedema

Drugmakers selling or developing treatments for attacks of hereditary angioedema, a rare swelling disorder.
−41.8%
over 3 months · S&P 500 −2.1%

Key indicators

Health
52 / 100
Fragile
Solid
Up over 1 year
4 of 5
Volatility
48%
Calm
Choppy
Profitability
−49%
Low
High
Health and price: against the other tags.